神経修復・再生の市場規模・シェア・成長分析 (製品別、手術別、地域別)：産業予測 (2025～2032年)

世界の神経修復・再生の市場規模は2023年に85億米ドルと評価され、2024年の95億5,000万米ドルから2032年には241億5,000万米ドルに成長し、予測期間（2025-2032年）のCAGRは12.3％で成長する見通しです。

神経修復・再生市場は、パーキンソン病、アルツハイマー病、その他の神経変性疾患などの神経疾患の罹患率の上昇によって大きな成長を遂げています。このような需要の急増を補完しているのが、先進的な治療法を開発している業界リーダーによる継続的な技術革新です。手術手技、生物製剤、医療機器の技術的進歩は治療効果を大幅に向上させ、市場拡大をさらに後押ししています。COVID-19パンデミックの継続的な影響により医療サービスは混乱し、慢性疾患を抱える患者の症状は悪化しています。それにもかかわらず、神経移植、幹細胞治療、神経保護薬などの治療法の進歩が予想され、見通しは続けて明るいです。アルツハイマー病協会が強調しているように、高齢化社会におけるアルツハイマー病の蔓延は、市場における効果的な神経修復ソリューションの必要性の高まりを強調しています。

目次

イントロダクション

• 分析目的
• 市場範囲
• 定義

分析手法

• 情報調達
• 二次・一次データの手法
• 市場規模予測
• 市場の想定と制約

エグゼクティブサマリー

• 市場の概要と展望
• 需給動向の分析
• セグメント別の機会分析

市場力学と展望

• 市場力学
  • 促進要因
  • 機会
  • 抑制要因
  • 課題
• ポーターの分析

市場の主な考察

• 主な成功要因
• 競合の程度
• 主な投資機会
• 市場魅力指数
• エコシステムマッピング
• IP分析
• 貿易分析
• スタートアップ分析
• 原材料の分析
• イノベーション・マトリクス
• パイプライン製品の分析
• マクロ経済指標
• マクロ経済指標
• 主な投資の分析

神経修復・再生市場：製品種類別

• 市場概要
• 神経刺激・神経調節デバイス
• 生体材料

神経修復・再生市場：用途別

• 市場概要
• 末梢神経損傷
• てんかん
• パーキンソン病
• アルツハイマー病

神経修復・再生市場規模：地域別

• 市場概要
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
• その他欧州
  • アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
• その他アジア太平洋
  • ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ
• 中東・アフリカ（MEA）
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情勢

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 市場における最近の活動
• 主要企業の市場シェア（2024年）

主要企業プロファイル

• Medtronic（US）
• Boston Scientific Corporation（US）
• Abbott Laboratories（US）
• Stryker Corporation（US）
• AxoGen, Inc.（US）
• Integra LifeSciences Holdings Corporation（US）
• Baxter International Inc.（US）
• Nevro Corp（US）
• LivaNova PLC（UK）
• Cyberonics Inc.（US）
• Orthofix Medical Inc.（US）
• Polyganics（Netherlands）
• Nuvectra Corporation（US）
• Polyganics BV（Netherlands）
• BioTime Inc.（US）
• Collagen Matrix, Inc.（US）
• Synovis Micro Companies Alliance, Inc.（US）
• StimGuard LLC（US）
• Nexeon MedSystems Inc.（US）
• Checkpoint Surgical, Inc.（US）

Global Nerve Repair and Regeneration Market size was valued at USD 8.5 billion in 2023 and is poised to grow from USD 9.55 billion in 2024 to USD 24.15 billion by 2032, growing at a CAGR of 12.3% during the forecast period (2025-2032).

The nerve repair and regeneration market is experiencing significant growth driven by the rising incidence of neurological disorders, such as Parkinson's, Alzheimer's, and other neurodegenerative diseases. This surge in demand is complemented by ongoing innovation from industry leaders who are developing advanced therapies. Technological advancements in surgical techniques, biologics, and medical equipment have greatly enhanced treatment efficacy, further propelling market expansion. The ongoing impacts of the COVID-19 pandemic have disrupted healthcare services, exacerbating symptoms in patients with chronic conditions. Nonetheless, the outlook remains positive, with anticipated advancements in therapies like nerve grafts, stem cell treatments, and neuroprotective drugs. As highlighted by the Alzheimer's Association, the prevalence of Alzheimer's disease in the aging population underscores the growing need for effective nerve repair solutions in the market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Nerve Repair and Regeneration market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Nerve Repair and Regeneration Market Segments Analysis

Global Nerve Repair and Regeneration Market is segmented by Product, Surgery and region. Based on Product, the market is segmented into Biomaterials and Neurostimulation and Neuromodulation Devices. Based on Surgery, the market is segmented into Direct Nerve Repair/Neurorrhaphy, Nerve Grafting, Stem Cell Therapy and Neurostimulation and Neuromodulation Surgeries. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Nerve Repair and Regeneration Market

The Global Nerve Repair and Regeneration market is primarily propelled by the rising incidence of neurological disorders such as multiple sclerosis, Parkinson's disease, Alzheimer's disease, and spinal cord injuries. As the global population continues to age and lifestyle factors contribute to an uptick in these conditions, the demand for effective therapies becomes increasingly critical. This surge in the market is particularly evident in developed countries with advanced healthcare systems, where nerve repair treatments are gaining significant traction. Overall, the combination of an aging populace and the prevalence of neurological afflictions is fostering robust growth in this sector.

Restraints in the Global Nerve Repair and Regeneration Market

A major challenge hindering the adoption of advanced nerve repair solutions, like stem cell therapies and regenerative medicine, is their high cost. These innovative treatments often demand substantial financial investments in both technology and research, making them inaccessible to many patients, particularly in low- and middle-income nations. The considerable treatment expenses further limit the feasibility of widespread implementation, posing a significant barrier to market growth, especially in regions facing healthcare budgetary limitations. As a result, the high pricing of these cutting-edge therapies plays a crucial role in restraining the overall expansion of the global nerve repair and regeneration market.

Market Trends of the Global Nerve Repair and Regeneration Market

The Global Nerve Repair and Regeneration market is witnessing a significant shift towards less invasive techniques, driven by the demand for shorter recovery times, reduced pain, and lower complication rates. The adoption of advanced technologies such as laparoscopic surgery, endoscopy, and robot-assisted procedures is becoming increasingly prevalent in the treatment of nerve injuries. This trend not only enhances patient outcomes but also streamlines clinical workflows, favorably expanding market potential. As healthcare providers and patients alike prioritize minimally invasive options, the market is poised for growth, reflecting an evolving therapeutic landscape in nerve regeneration and repair.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors of The Market
• Degree Of Competition
• Top Investment Pockets
• Market Attractive Index
• Ecosystem Mapping
• IP Analysis
• Trade Analysis
• Startup Analysis
• Raw Material Analysis
• Innovation Matrix
• Pipeline Product Analysis
• Macroeconomic Indicators
• Macroeconomic Indicators
• Top Investment Analysis

Global Nerve Repair and Regeneration Market by Product Type

• Market Overview
• Neurostimulation and Neuromodulation Devices
• Biomaterials

Global Nerve Repair and Regeneration Market by Application

• Market Overview
• Peripheral Nerve Injury
• Epilepsy
• Parkinson's Disease
• Alzheimer's Disease

Global Nerve Repair and Regeneration Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
• Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
• Rest of Asia-Pacific
  • Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2024

Key Company Profiles

• Medtronic (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AxoGen, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Integra LifeSciences Holdings Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Baxter International Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nevro Corp (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LivaNova PLC (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cyberonics Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Orthofix Medical Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Polyganics (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nuvectra Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Polyganics BV (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioTime Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Collagen Matrix, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Synovis Micro Companies Alliance, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• StimGuard LLC (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nexeon MedSystems Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Checkpoint Surgical, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments